Figure from Ramos et al. (pp 95–103).
INCLUDE WHEN CITING Published online May 27, 2022; DOI: 10.3171/2022.3.JNS22564.
Disclosures Dr. Hadjipanayis reports receiving royalties from NX Development Corp. and being a consultant for Synaptive Medical, NX Development Corp., Hemerion, and Stryker.
ACCOMPANYING ARTICLE DOI: 10.3171/2022.3.JNS212399.
Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg. 2011;115(1):3–8.
Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95(2):190–198.
Brown TJ, Brennan MC, Li M, et al. Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis. JAMA Oncol. 2016;2(11):1460–1469.
Rahman M, Abbatematteo J, De Leo EK, et al. The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma. J Neurosurg. 2017;127(1):123–131.
McGirt MJ, Mukherjee D, Chaichana KL, Than KD, Weingart JD, Quinones-Hinojosa A. Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery. 2009;65(3):463–470.
Shah AH, Mahavadi A, Di L, et al. Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection. J Neurooncol. 2020;148(3):501–508.
Di L, Shah AH, Mahavadi A, et al. Radical supramaximal resection for newly diagnosed left-sided eloquent glioblastoma: safety and improved survival over gross-total resection. J Neurosurg. Published online May 27, 2022. doi: 10.3171/2022.3.JNS212399
Hartmann C, Hentschel B, Wick W, et al. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathol. 2010;120(6):707–718.
Verhaak RGW, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98–110.
Wang Q, Hu B, Hu X, et al. Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell. 2017;32(1):42–56.e6.
Rooj AK, Ricklefs F, Mineo M, et al. MicroRNA-mediated dynamic bidirectional shift between the subclasses of glioblastoma stem-like cells. Cell Rep. 2017;19(10):2026–2032.
Tucha O, Smely C, Preier M, Lange KW. Cognitive deficits before treatment among patients with brain tumors. Neurosurgery. 2000;47(2):324–334.
Taphoorn MJB, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol. 2004;3(3):159–168.
Li W, Mai X, Liu C. The default mode network and social understanding of others: what do brain connectivity studies tell us. Front Hum Neurosci. 2014;8:74.
Sandhu Z, Tanglay O, Young IM, et al. Parcellation-based anatomic modeling of the default mode network. Brain Behav. 2021;11(2):e01976.
Dadario NB, Brahimaj B, Yeung J, Sughrue ME. Reducing the cognitive footprint of brain tumor surgery. Front Neurol. 2021;12:711646.
Harris RJ, Bookheimer SY, Cloughesy TF, et al. Altered functional connectivity of the default mode network in diffuse gliomas measured with pseudo-resting state fMRI. J Neurooncol. 2014;116(2):373–379.
Zhang H, Shi Y, Yao C, et al. Alteration of the intra- and cross-hemisphere posterior default mode network in frontal lobe glioma patients. Sci Rep. 2016;6:26972.
Wefel JS, Noll KR, Scheurer ME. Neurocognitive functioning and genetic variation in patients with primary brain tumours. Lancet Oncol. 2016;17(3):e97–e108.
Glenn CA, Baker CM, Conner AK, et al. An examination of the role of supramaximal resection of temporal lobe glioblastoma multiforme. World Neurosurg. 2018;114:e747–e755.
Roh TH, Kang SG, Moon JH, et al. Survival benefit of lobectomy over gross-total resection without lobectomy in cases of glioblastoma in the noneloquent area: a retrospective study. J Neurosurg. 2020;132(3):895–901.
Li YM, Suki D, Hess K, Sawaya R. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: can we do better than gross-total resection?. J Neurosurg. 2016;124(4):977–988.
Mampre D, Ehresman J, Pinilla-Monsalve G, et al. Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes. Br J Neurosurg. 2018;32(5):528–535.
Pessina F, Navarria P, Cozzi L, et al. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience. J Neurooncol. 2017;135(1):129–139.
Schucht P, Knittel S, Slotboom J. 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma. Acta Neurochir (Wien). 2014;156(2):305–312.
Neira JA, Ung TH, Sims JS, et al. Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance. J Neurosurg. 2017;127(1):111–122.
Bowden SG, Neira JA, Gill BJA, et al. Sodium fluorescein facilitates guided sampling of diagnostic tumor tissue in nonenhancing gliomas. Neurosurgery. 2018;82(5):719–727.
Schebesch KM, Brawanski A, Doenitz C, et al. Fluorescence-guidance in non-gadolinium enhancing, but FET-PET positive gliomas. Clin Neurol Neurosurg. 2018;172:177–182.
Schupper AJ, Rao M, Mohammadi N, et al. Fluorescence-guided surgery: a review on timing and use in brain tumor surgery. Front Neurol. 2021;12:682151.
Khalafallah AM, Rakovec M, Bettegowda C, et al. A crowdsourced consensus on supratotal resection versus gross total resection for anatomically distinct primary glioblastoma. Neurosurgery. 2021;89(4):712–719.
Dandy WE. Removal of right cerebral hemisphere for certain tumors with hemiplegia. J Am Med Assoc. 1928;90(11):823–825.
Eichberg DG, Shah AH, Di L, et al. Stimulated Raman histology for rapid and accurate intraoperative diagnosis of CNS tumors: prospective blinded study. J Neurosurg. 2021;134(1):137–143.
Di L, Eichberg DG, Huang K, et al. Stimulated Raman histology for rapid intraoperative diagnosis of gliomas. World Neurosurg. 2021;150:e135–e143.
Eatz TA, Eichberg DG, Lu VM, Di L, Komotar RJ, Ivan ME. Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review. J Neurooncol. 2022;156(2):233–256.
Brown TJ, Brennan MC, Li M, et al. Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis. JAMA Oncol. 2016;2(11):1460–1469.
Shah AH, Mahavadi A, Di L, et al. Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection. J Neurooncol. 2020;148(3):501–508.
Vivas-Buitrago T, Domingo RA, Tripathi S, et al. Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma. J Neurosurg. 2022;136(1):1–8.
Davis L, Martin J, Goldstein SL, Ashkenazy M. A study of 211 patients with verified glioblastoma multiforme. J Neurosurg. 1949;6(1):33–44.
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1036 | 1035 | 107 |
Full Text Views | 255 | 255 | 80 |
PDF Downloads | 292 | 292 | 92 |
EPUB Downloads | 0 | 0 | 0 |